Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Weight management

Recent news which mentions Weight management

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Business News Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Business News Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Novo Nordisk A/S Obesity US: News
From CNBC.com News
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Tags Technology Health care industry Breaking News: Technology
From CNBC.com News
If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
Tags Weight management Personal investing Stock markets
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Markets Wall Street Stock markets
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Small Business Obesity Personnel
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Biotechnology US: News Renter's insurance
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Health care industry Health WW Grainger Inc
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Animals Health care industry Zoetis Inc
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Employee benefits Health & Science Health Insurance
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags US: News Business Biotechnology
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Novo Nordisk A/S Altimmune Inc Biotechnology
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Pharmaceuticals Biotechnology US: News
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Biotechnology US: News Business
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Mobile Health & Science Weight management
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Diabetes Breaking News: Markets Exercise
From CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Biotech and Pharmaceuticals Business News Mergers and acquisitions
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
Tags Health & Science Companies Eli Lilly and Co
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Tags Companies Health & Science Science
From CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
Tags Health & Science Companies Law and Regulation
From CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Tags Health & Science Companies Business News
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Tags Business News Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Tags Health care industry Mergers and acquisitions Biotech and Pharmaceuticals
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Tags Weight loss surgery Breaking news Pharmaceuticals
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
Tags Weight management Eli Lilly and Co Health & Science
From CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Tags Eli Lilly and Co Weight management Social issues
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Obesity Novo Nordisk A/S Medication
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags Business News Biotech and Pharmaceuticals Amgen Inc
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Pharmaceuticals Breaking news Novo Nordisk A/S
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.